Literature DB >> 6348173

Surface markers of human natural killer cells as analyzed in a modified single cell cytotoxicity assay on poly-L-lysine coated cover slips.

M Vargas-Cortes, U Hellström, P Perlmann.   

Abstract

A modified single cell cytotoxicity assay using poly-L-lysine coated cover slips (PLL-SCCA) was employed to study the frequency and surface marker profile of human peripheral blood lymphocytes (PBL) with NK reactivity against K 562 target cells. When compared with the previously described agarose single cell cytotoxicity assay (A-SCCA) identical results were obtained. For 13 donors tested 18.1 +/- 4.4% of the PBL formed conjugates with K 562 and 2.7 +/- 1.6% displayed NK reactivity. In contrast to the A-SCCA, the PLL-modified assay permits direct identification of both conjugate forming (TBC) and cytolytic PBL (NK) by means of surface markers. Indirect immunofluorescence studies with monoclonal anti-PBL antibodies revealed that neither the plating procedures nor the incubation conditions employed affected the expression of the antigens recognized by these reagents. This method of directly identifying NK cells showed that OKM1+ cells were enriched among the NK cells as compared to PBL and TBC (55% vs. 23% and 43%, respectively). In contrast, the OKT3+ or Leu1+ fraction of the NK cells was reduced as compared to PBL and TBC. However, using this method of identification at the effector cell level, a substantial proportion of the NK cells were OKT3+ or Leu1+ (57% or 58% respectively, 7 donors). Approximately 25% of the NK cells were Leu2a+ and 30% were Leu3a+, respectively. However, the size of the Leu3a+ fraction varied considerably with individual donors and the size of this fraction appeared to be inversely related to that of the donors NK pool.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6348173     DOI: 10.1016/0022-1759(83)90114-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  Ability of recombinant interferon gamma in vitro to restore the defective polymorphonuclear-cell- but not lymphocyte-mediated cytotoxic activities in patients with myelodysplastic syndromes.

Authors:  G De Sanctis; V Bottari; A Frezzolini; M Ficcardi; G De Rossi; M C Petti; F Mandelli; L Fontana
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

2.  Natural killer cell function is not diminished in the healthy aged and is proportional to the number of NK cells in the peripheral blood.

Authors:  G J Ligthart; H R Schuit; W Hijmans
Journal:  Immunology       Date:  1989-11       Impact factor: 7.397

3.  MHC nonrestricted cytotoxic T cell clones with selective specificity from patients with transitional cell carcinoma (TCC) of the urinary bladder.

Authors:  Y Hansson; M Vargas-Cortes; S Paulie; P Perlmann
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  In vitro modulation of natural killer cell activity in non-Hodgkin's lymphoma patients after therapy.

Authors:  B A Mehta; M N Satam; S H Advani; J J Nadkarni
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.

Authors:  E Jezewska; M Björkholm; R Giscombe; G Holm; O Tullgren
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

6.  Decreased NK activity in hairy cell leukemia (HCL): an analysis at the cellular level.

Authors:  L Fontana; G De Rossi; G De Sanctis; F Ensoli; M Lopez; L Annino; F Mandelli
Journal:  Blut       Date:  1986-08

7.  Natural killer (NK) cell activity during HIV infection: a decrease in NK activity is observed at the clonal level and is not restored after in vitro long-term culture of NK cells.

Authors:  D Scott-Algara; F Vuillier; A Cayota; G Dighiero
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

Review 8.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.